Corporate / CVC · 1 deal
Every published round Döhler Ventures took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| All G | Bridge / extension | 8 Dec 2025 | $10m | Participant | Startup Daily (12 Dec 2025), SmartCompany, Startup Daily (9 Dec 2025), AgFunderNews |
Companies Döhler Ventures has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| All G | 8 Dec 2025, Bridge / extension | 1 | 0 |
Fund closes reported for Döhler Ventures, as distinct from the investments it has made.
Companies Döhler Ventures has backed that another company then bought. An exit for the holding, not a deal Döhler Ventures did.
Stories naming Döhler Ventures. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Australian food-tech firm All G has launched a low-iron, fermentation-derived lactoferrin in the US, producing multiple tonnes yearly via a Chinese manufacturer, with European capacity and a human-equivalent version planned.
Precision fermentation startup All G banked A$10 million through a convertible note and teamed up with French dairy ingredients maker Armor Protéines to sell lactoferrin, targeting a first product launch in early 2026.